(1) Benzathine penicillin G, [2] [3] [4] Although there has been little evidence to indicate that the Treponema pallidum is any less susceptible to penicillin now than when it was introduced in 1943, the sharp increase in incidence of syphilis over the past few years not only suggested that it was time to re-evaluate our methods of treatment but also provided the cases necessary for such an undertaking.
In July, 1965 , the Venereal Disease Program initiated an evaluation to establish the current comparative effectiveness of schedules now recommended by the Public Health Service for the treatment of early syphilis and to determine the efficacy of a new injectable antibiotic, spectinomycin (actinospectacin, Trobicin). Clark and Yobs (1963 , 1964 , 1966 have extensively studied the effects of spectinomycin in experimental rabbit syphilis. They have reported that a daily injection of 1 -0 mg./kg. for 7 days (total, 7 mg./kg.) was curative in experimental early lesion rabbit syphilis (1966a). Vurther, unpublished data by these authors (1966b) indicate that seven single daily injections of 0 5 mg./kg. are also curative (total 3 5 mg./kg.).
Single doses of 1 2 to 1 6 g. spectinomycin have been shown by Willcox (1962) , Laird and Taylor (1962) , and Tiedemann, Hackney, and Price (1965) to be an effective treatment for gonorrhoea in males. In a recent study of spectinomycin in gonorrhoea in females by Lucas, Price, Thayer, and Schroeter (1967) , a single injection of 4 g. was found comparable in efficacy to 2-4 million units aqueous procaine penicillin G.
In view of the lack of toxicity and paucity of adverse reactions associated with spectinomycin and its high degree of efficacy in experimental syphilis, it was felt that an evaluation in syphilotherapy was indicated. 244
Nine city or county health departments* agreed to co-operate in the study.
Selection of Cases and Examination of Patients
Selection of cases is limited to darkfield-positive primary or secondary syphilis and re-infected patients meeting these criteria are accepted. Consideration is also given to permanence of residence and distance from the clinic, and the patients' intelligence and willingness to co-operate in the study.
The The erythromycin previously evaluated by the Public Health Service (Brown, Simpson, Moore, Price, and Weinstein, 1963) and upon which the recommended schedule is based was propionyl erythromycin lauryl sulphate. Cholestatic hepatitis, however, has been reported after prolonged usage of this preparation. Although it was anticipated that it would be somewhat less effective because of the lower blood levels produced, the base form of erythromycin was therefore selected for this evaluation.
Drugs were secured by the Venereal Disease Program and distributed to the co-operating clinics so that identical preparations would be evaluated by the participants.
Results of Treatment
This report includes the results of treatment during the first year of observation. The statistical method of analysis is that described by Iskrant, Bowman, and Donohue (1948) for evaluating antisyphilitic therapy. Since the critical period for the occurrence of relapse or re-infection covers roughly the 3rd to the 9th month following treatment, these preliminary data cover a period sufficiently long to give a reliable comparison of the relative efficacy of the various treatment schedules. The determination of cure, however, must await more prolonged observation.
In Table I the cumulative re-treatment rates (including both relapse and re-infection) at the 3rd, 6th, 9th, and 12th month of observation are shown by schedule for total cases treated and for those with With the possible exceptions of the 16 g. spectinomycin schedule, which decreased from 38.5 to 33 4 per cent., and the tetracycline schedule, which decreased from 5 6 to 0 0 per cent., only very minor changes resulted from the exclusion of previously infected cases. Therefore, regardless of the group analysed, it is obvious that the two spectinomycin schedules and the erythromycin schedule are unsatisfactory for the treatment of early syphilis; that the three penicillin schedules are approximately equal in efficacy; and that the tetracycline schedule is at least as efficacious as the penicillin schedules.
The first indication that spectinomycin was less effective than penicillin was seen in the length of time required for the darkfield to become negative. 84 per cent. of the patients treated with aqueous procaine penicillin were darkfield-negative on the second day of observation after one injection and the remainder were negative on the 3rd day. Only 44 per cent. of the spectinomycin-treated patients were negative on the second day of observation and 18 per cent. required 4 days or more for the treponemes to disappear. One patient on the 16 g. schedule was still positive on the 8th day of observation after receiving five injections of spectinomycin. This patient was considered to be a treatment failure and was then re-treated with benzathine penicillin G.
The post-treatment observation rate (based on total observation period rather than number of scheduled observations completed) is only 60 per cent. Apparently less effort has been expended in keeping the penicillin-treated patients under observation-the rates for these three schedules range from 48 to 60 per cent.; for the four schedules employing other antibiotics, the post-treatment observation rates range from 64 to 69 per cent.
Another factor which may cause a bias in results is the distribution of cases by stage of syphilis. Only 32 patients with sero-negative primary syphilis are included in the evaluation and all made a satisfactory response to treatment. These cases have been omitted from the Figure, in which only the results of treatment in previously uninfected sero-positive primary syphilis and secondary syphilis are compared. Because the number of cases included in the evaluation is small and there is no appreciable difference in re-treatment rates between the two spectinomycin schedules or among the three penicillin schedules, the results are shown by therapeutic agent rather than by schedule of treatment.
The data in the Figure (opposite FIGURE.-Cumulative re-treatment rates during 12 months' observation by antibiotic administered (Previously untreated cases). far in excess of the previously-discussed schedules shown to be effective in experimental syphilis.
On the other hand, the poor results among patients treated with erythromycin appear to be definitely related to body-weight dosage. The re-treatment rate among patients receiving less than 300 mg./kg. is more than triple that among those receiving more than 300 mg./kg. This is in spite of the fact that the majority of the lower dosage cases were in the primary stage while the majority of the higher dosage cases were in the secondary stage 
